治療方法

Japanese Patent JP7475324

B2

The present invention relates to methods of treating subjects having heart failure with preserved ejection fraction (HFpEF) with a sustained-delivery formulation of cardiotonic 5-(pyridinyl)-2(1H)-pyridinone compounds.

JP2013523806	Sultam compound
JP5372767	2-[(2-Substituted) -Indolizine-3-yl] -2-oxo-acetamide derivative as an antifungal agent
JP5307718	3-Aminoimidazole [1,2-a] pyridine derivative with SGLT1 and SGLT2 inhibitory activity for treating type 1 and type 2 diabetes

Kay, david

JP2021210184A

April 26, 2024

December 24, 2021

Click for automatic bibliography generation  

Baker Hart and Diabates Institute

A61K31/444; A61K9/08; A61K9/22; A61K47/26; A61K47/32; A61K47/34; A61K47/36; A61K47/38; A61P9/04

JP2014521727A

Chinese Journal of Current Clinical Medicine,2011年,Vol.9, No.3,pp.148-150
Journal of the American College of Cardiology,2013年,Vol.62,No.16,pp.e147-e239
循環器病の診断と治療に関するガイドライン(2010年度合同研究班報告),急性心不全治療ガイドライン(2011改訂版),2013年09月20日,pp.1-81
Circ Heart Fail,2010年,Vol.3,pp.588-595
European Heart Journal,2014年08月,Vol.35,pp.3103-3112
Heart Failure Clin.,2014年07月,Vol.10, Issue 3,pp.407-418

Patent Attorney Corporation Tanikawa International Patent Office

Previous Patent: Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of ...

Next Patent: gaming machine